GO:0034136 negative regulation of toll-like receptor 2 signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034136 describes any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 2 (TLR2) signaling.
• TLR2 signaling is initiated by microbial ligands and is tightly controlled to prevent excessive inflammation.
• Negative regulators such as Tollip and SOCS1 are essential for terminating TLR2 signaling and maintaining immune homeostasis.
• Dysregulation of TLR2 negative regulation is linked to chronic inflammatory diseases, including atopic dermatitis and chronic hepatitis B.
• Adiponectin and other host factors can inhibit TLR2 signaling, linking metabolism to immune regulation.
• CRISPR-based models (knockout, knock-in, overexpression) are powerful tools to dissect the causal roles of negative regulators in TLR2 signaling.
Description
Toll-like receptor 2 (TLR2) is a key pattern recognition receptor that detects a wide range of microbial components, including lipoproteins and lipoteichoic acid, and initiates inflammatory signaling. While TLR2 activation is crucial for host defense, uncontrolled signaling can lead to chronic inflammation and tissue damage. Therefore, negative regulation of TLR2 signaling (GO:0034136) is essential to resolve inflammation and maintain immune homeostasis. This GO term encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of TLR2 signaling. Understanding these regulatory mechanisms is critical for researchers studying infectious diseases, autoimmunity, and cancer, as they provide potential targets for therapeutic intervention.
negative regulation of toll-like receptor 2 signaling pathway At A Glance
| GO ID | GO:0034136 |
|---|---|
| GO term | negative regulation of toll-like receptor 2 signaling pathway |
| Ontology | biological_process |
| Synonym | negative regulation of TLR2 signaling pathway |
| Major function | Termination or attenuation of TLR2-mediated inflammatory signaling |
| Related pathway | Toll-like receptor signaling pathway |
| Key regulators | Tollip, SOCS1, Adiponectin |
| Disease relevance | Chronic inflammation, atopic dermatitis, hepatitis B |
What Is GO:0034136?
GO:0034136, negative regulation of toll-like receptor 2 signaling pathway, refers to any biological process that negatively regulates the signaling cascade triggered by TLR2. This includes mechanisms that degrade or inhibit TLR2 itself, block downstream adaptor proteins, or induce negative feedback loops, ultimately dampening the inflammatory response.
Why Is negative regulation of toll-like receptor 2 signaling pathway Important in Cell Biology?
Negative regulation of TLR2 signaling is vital for preventing excessive inflammation and autoimmune pathology. Dysregulation of this process contributes to chronic inflammatory diseases such as atopic dermatitis and chronic hepatitis B. Moreover, understanding how TLR2 signaling is turned off can inform the development of new therapies for inflammatory disorders and cancer.
• Prevents chronic inflammation by terminating TLR2 signaling after pathogen clearance.
• Maintains immune homeostasis and prevents autoimmunity.
• Dysregulation is linked to atopic dermatitis and chronic hepatitis B.
• Adiponectin-mediated inhibition links metabolic status to TLR2 regulation.
• Provides targets for anti-inflammatory drug development.
• Essential for understanding host-pathogen interactions.
• Relevant to cancer immunotherapy due to TLR2 expression on immune cells.
• Helps explain inter-individual variability in inflammatory responses.
What Happens During negative regulation of toll-like receptor 2 signaling pathway?
Initiation of TLR2 signaling
In simple terms: TLR2 recognizes microbial components and starts a signaling cascade.
TLR2 signaling is initiated when TLR2 heterodimerizes with TLR1 or TLR6 and binds microbial ligands such as lipoproteins, leading to recruitment of adaptor proteins like MyD88 and activation of NF-kB and MAP kinases.
Negative feedback by Tollip
In simple terms: Tollip acts as a brake on TLR2 signaling.
Tollip (Toll-interacting protein) is a negative regulator that associates with TLR2 and inhibits IL-1R-associated kinase (IRAK) activation, thereby dampening downstream signaling.
SOCS1-mediated inhibition
In simple terms: SOCS1 shuts down TLR2 signaling by targeting key molecules.
Suppressor of cytokine signaling 1 (SOCS1) is induced upon TLR2 activation and negatively regulates the pathway by inhibiting NF-kB and STAT1 activation, as shown in Langerhans cells.
Adiponectin-mediated suppression
In simple terms: Adiponectin, a metabolic hormone, can block TLR2 signaling.
Adiponectin inhibits TLR family-induced signaling, including TLR2, by interfering with NF-kB activation, thus linking metabolic status to immune regulation.
Other regulatory mechanisms
In simple terms: Additional proteins and microRNAs fine-tune TLR2 signaling.
Other negative regulators include A20, IRAK-M, and microRNAs that target TLR2 or its adaptors. For example, the hepatitis B precore protein regulates TLR2 expression in chronic hepatitis B.
Key Genes Involved in GO:0034136 negative regulation of toll-like receptor 2 signaling pathway
Key genes and proteins involved in negative regulation of TLR2 signaling include Tollip, SOCS1, and Adiponectin, among others.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TOLLIP | Inhibits IRAK activation downstream of TLR2 | Negative regulator; KO increases inflammation |
| SOCS1 | Inhibits NF-kB and STAT1 in TLR2 signaling | Key feedback inhibitor; KO leads to hyperresponsiveness |
| ADIPOQ | Adiponectin inhibits TLR2-induced NF-kB | Links metabolism to immune regulation |
| TLR2 | Receptor initiating signaling | Target for negative regulation |
| MYD88 | Adaptor protein in TLR2 signaling | Downstream target of negative regulators |
| IRAK1 | Kinase activated by TLR2 | Inhibited by Tollip |
| IRAK4 | Kinase upstream of IRAK1 | Potential target of negative regulation |
| TRAF6 | E3 ubiquitin ligase in TLR2 pathway | Regulated by A20 and SOCS1 |
| NFKB1 | Transcription factor driving inflammation | Inhibited by SOCS1 and Adiponectin |
| MAP3K7 | TAK1 kinase in TLR2 pathway | Regulated by negative feedback |
| TICAM1 | TRIF adaptor in TLR2 signaling | Alternative adaptor; negatively regulated |
| CD14 | Co-receptor for TLR2 ligands | Modulates TLR2 activation |
| LY96 | MD-2 co-receptor | Assists TLR2 ligand recognition |
| PDCD1 | PD-1 on Langerhans cells regulates APC activity | Immune checkpoint in TLR2 context |
| SOCS3 | Inhibits cytokine signaling | Potential cross-talk with TLR2 |
| A20 | Ubiquitin-editing enzyme | Negative regulator of NF-kB |
| IRAK3 | IRAK-M, inhibits IRAK1/4 | Negative regulator of TLR2 |
| CASP4 | Caspase-4 involved in inflammasome | Linked to TLR2 in monocytes |
How Is negative regulation of toll-like receptor 2 signaling pathway Regulated?
Negative regulation of TLR2 signaling is achieved through multiple mechanisms, including degradation of signaling components, inhibition of kinases, and induction of negative feedback loops. Tollip and SOCS1 are rapidly induced upon TLR2 activation and act to terminate the signal. Adiponectin provides a metabolic checkpoint that suppresses TLR2 signaling. Additionally, viral proteins such as hepatitis B precore protein can modulate TLR2 expression.
negative regulation of toll-like receptor 2 signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SOCS1 | Atopic dermatitis | Keratinocyte-specific KO or overexpression |
| TOLLIP | Inflammatory bowel disease | Intestinal epithelial KO |
| ADIPOQ | Metabolic syndrome | Adiponectin KO mice |
| TLR2 | Chronic hepatitis B | Hepatocyte-specific TLR2 KO |
| PDCD1 | Cancer immunotherapy | PD-1 KO in Langerhans cells |
Atopic Dermatitis
In atopic dermatitis, TLR2/SOCS1-dependent modulation of Langerhans cells is impaired, leading to chronic inflammation. JAK inhibitors can restore SOCS1 expression and dampen TLR2 signaling.
Chronic Hepatitis B
The hepatitis B precore protein regulates TLR2 expression, and its dysregulation may contribute to persistent inflammation and viral persistence.
Metabolic Disorders
Adiponectin-mediated inhibition of TLR2 signaling links obesity and insulin resistance to chronic low-grade inflammation.
Cancer
TLR2 signaling in immune cells can promote tumor progression; negative regulators such as SOCS1 may suppress pro-tumor inflammation.
From negative regulation of toll-like receptor 2 signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Tollip negatively regulate TLR2 signaling? | TOLLIP knockout cell line (e.g., THP-1) |
| What is the role of SOCS1 in TLR2 signaling? | SOCS1 knockout or overexpression in keratinocytes |
| How does Adiponectin inhibit TLR2? | ADIPOQ knockout adipocytes or hepatocytes |
| Does a point mutation in TLR2 affect negative regulation? | TLR2 point-mutation knock-in mice |
| Can we tag endogenous Tollip for live imaging? | TOLLIP knock-in with fluorescent tag |
| Which genes regulate TLR2 signaling? | CRISPR library screening in macrophages |
How to Study the negative regulation of toll-like receptor 2 signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR KO screening | Loss-of-function effects on TLR2 signaling | Identify novel negative regulators |
| RNA-seq | Transcriptional changes | Measure feedback gene induction |
| Proteomics | Protein interactions and modifications | Map signaling complexes |
| Live-cell imaging | Protein localization and dynamics | Study TLR2 internalization |
| Flow cytometry | Surface TLR2 expression | Quantify receptor levels |
| ELISA | Cytokine secretion | Measure inflammatory output |
| Western blot | Phosphorylation of NF-kB | Assess pathway activation |
| Reporter assays | NF-kB transcriptional activity | High-throughput screening |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify negative regulators of TLR2 signaling by selecting for cells with enhanced NF-kB activation upon TLR2 stimulation.
RNA Sequencing
RNA-seq after TLR2 activation in wild-type and knockout cells reveals transcriptional changes and feedback loops.
Proteomics
Mass spectrometry can identify post-translational modifications and interaction partners of TLR2 signaling components.
Imaging
Live-cell imaging of tagged TLR2 or Tollip can visualize trafficking and degradation dynamics.
How CRISPR Can Be Used to Study GO:0034136 negative regulation of toll-like receptor 2 signaling pathway
Knockout
CRISPR knockout of negative regulators such as TOLLIP or SOCS1 leads to enhanced TLR2 signaling, confirming their inhibitory roles.
Point Mutation
Introducing point mutations in TLR2 or its regulators can dissect specific phosphorylation or ubiquitination sites required for negative regulation.
Knock-in
Knock-in of tagged versions of Tollip or SOCS1 allows for live-cell imaging and proteomic analysis of endogenous complexes.
Overexpression
Overexpression of Adiponectin or SOCS1 can suppress TLR2 signaling, providing gain-of-function evidence for their negative regulatory roles.
How EDITGENE Supports negative regulation of toll-like receptor 2 signaling pathway Research
Researchers studying negative regulation of toll-like receptor 2 signaling pathway-related genes often need to determine whether a candidate gene is causally involved in dampening TLR2 signaling or is merely a bystander. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of toll-like receptor 2 signaling pathway research.
Frequently Asked Questions About negative regulation of toll-like receptor 2 signaling pathway
What is GO:0034136?
GO:0034136 is the Gene Ontology term for negative regulation of toll-like receptor 2 signaling pathway, describing any process that stops or reduces TLR2 signaling.
What genes are involved in negative regulation of TLR2 signaling?
Key genes include TOLLIP, SOCS1, ADIPOQ, and A20, among others.
How does Tollip inhibit TLR2 signaling?
Tollip binds to TLR2 and inhibits IRAK activation, thereby dampening downstream NF-kB signaling.
What is the role of SOCS1 in TLR2 signaling?
SOCS1 is induced by TLR2 activation and negatively regulates the pathway by inhibiting NF-kB and STAT1.
Can adiponectin suppress TLR2 signaling?
Yes, adiponectin inhibits TLR family-induced signaling, including TLR2, by interfering with NF-kB activation.
Which diseases are linked to defective TLR2 negative regulation?
Atopic dermatitis, chronic hepatitis B, and metabolic disorders are associated with dysregulated TLR2 negative regulation.
How can I study negative regulation of TLR2 signaling?
CRISPR knockout, knock-in, overexpression, and library screening are powerful approaches.
What models are available for TLR2 negative regulation research?
Knockout mice, cell lines, and primary immune cells are commonly used.
What is the clinical relevance of TLR2 negative regulation?
It is critical for preventing chronic inflammation and is a target for anti-inflammatory therapies.
How does EDITGENE support TLR2 research?
EDITGENE offers custom CRISPR services including KO, point mutation, knock-in, overexpression, and screening.
Conclusion
Negative regulation of TLR2 signaling (GO:0034136) is a critical process that prevents excessive inflammation and maintains immune homeostasis. Key regulators such as Tollip, SOCS1, and Adiponectin have been identified, and their dysregulation contributes to various diseases. CRISPR-based models are invaluable for dissecting these mechanisms and developing new therapies.
References
- 2. Zhang G et al.. 2002. Negative regulation of toll-like receptor-mediated signaling by Tollip.. J Biol Chem 277(9):7059-65 PMID: 11751856
- 3. Muzio M et al.. 2000. Toll-like receptor family and signalling pathway.. Biochem Soc Trans 28(5):563-6 PMID: 11044375
- 4. Peña-Cruz V et al.. 2010. PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.. J Invest Dermatol 130(9):2222-30 PMID: 20445553
- 5. Krause K et al.. 2025. Streptococcus pyogenes EVs induce the alternative inflammasome via caspase-4/-5 in human monocytes.. EMBO Rep 26(19):4847-4885 PMID: 40925957
- 6. Deng Y et al.. 2025. Langerhans Cell Modulation in Atopic Dermatitis Is TLR2/SOCS1-Dependent and JAK Inhibitor-Sensitive.. Allergy 80(9):2586-2599 PMID: 40631910
- 7. Yamaguchi N et al.. 2005. Adiponectin inhibits Toll-like receptor family-induced signaling.. FEBS Lett 579(30):6821-6 PMID: 16325814
- 8. Visvanathan K et al.. 2007. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein.. Hepatology 45(1):102-10 PMID: 17187404
